Sen. Susan Collins

Senators target ‘Rx gag clauses’

April 17, 2018 by Chain Drug Review Claire McCaskill, Debbie Stabenow, pharmacy gag clauses, Sen. Susan Collins Issue 04-09-2018, News

WASHINGTON — Three senators last month introduced legislation that they say will bring more transparency to prescription drug pricing. Sens. Susan Collins (R., Maine), Claire McCaskill (D., Mo.) and Debbie Stabenow (D., Mich.) introduced the Patient Right to Know Drug Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), which would

Senate report calls for higher generics usage

January 19, 2015 by John Schultz and Chain Drug Review Affordable Prescription Drugs, biologics exclusivity, Centers for Medicare & Medicaid Services, drug costs, generic drug price spikes, generic drug use, generic drugs, Generic Pharmaceutical Association, GPhA, Medicare Part D, Medicare Payment Advisory Committee, MedPAC, Peter Welch, Ralph Neas, Sen. Bill Nelson, Sen. Susan Collins, Senate Special Committee on Aging, Steve Stivers 2015, Issue 01-19-2015, News, Pharmacy

WASHINGTON — Providing incentives to prescription drug plan sponsors that increase generic drug use is among recommendations that the Senate Special Committee on Aging unveiled last month in a bipartisan report that focuses on ways to increase the utilization of generics within the Medicare Part D program. The panel also heard about industry issues beyond